Quantcast

Latest GlaxoSmithKline Stories

2014-07-17 08:28:43

PITTSBURGH, July 17, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that the U.S. District Court for the District of New Jersey granted its motion for a permanent injunction against GlaxoSmithKline (GSK) in relation to Paroxetine CR, the generic version of GSK's Paxil(®) CR. GSK is now precluded from supplying product to Apotex, which marketed the product as an authorized generic. Mylan had previously been awarded damages in the amount of $106,700,000 by the District...

2014-07-08 23:08:08

Matters Involving Ongoing Litigation to Be Discussed DALLAS (PRWEB) July 08, 2014 Parties involved in lawsuits regarding the anti-psychotic drug Risperdal are scheduled to meet in the Philadelphia Court of Common Pleas to hold a conference to discuss moving litigation forward, the national law firm of Baron and Budd reports. The plaintiffs in the lawsuits accuse Janssen Pharmaceuticals, as well as parent company Johnson & Johnson, of allegedly failing to properly warn users of...

2014-07-02 08:26:15

CARLSBAD, Calif., July 2, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $1 million payment from GlaxoSmithKline (GSK) related to the advancement of its program to develop antisense drugs to treat hepatitis B virus (HBV). http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO "Our collaboration with GSK has been very productive resulting in three novel antisense drugs in our pipeline. We look forward to continuing to advance...

2014-06-27 23:07:53

GlaxoSmithKline agreed to pay $105 million to settle claims by California, New York, and more than 40 other states that it illegally promoted three of its antidepressants and asthma drugs. Flood Law Group is investigating potential Paxil claims in light of this recent settlement. (PRWEB) June 27, 2014 GlaxoSmithKline agreed to pay $105 million to settle claims by California, New York, and more than 40 other states that it illegally promoted three of its antidepressants and asthma drugs,...

2014-06-26 12:26:45

LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Chronic Obstructive Pulmonary Disorder (COPD) - KOL Insight and Consensus Outlookhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/chronic_obstructive_pulmonary_disorder_copd_kol_insight_consensus_outlook.html The prevalence of Chronic Obstructive Pulmonary Disorder (COPD) is increasing globally, its impact on the wider health economy is significant and there remains considerable...

2014-06-23 23:10:52

In Addition, The $105 Million Paxil Lawsuit Settlement with GlaxoSmithKline and Dozens of States, Prevents the Company From Paying Incentives to Drug Reps That Encourage Off-Label Use of Paxil and Other Medications. Columbus, OH (PRWEB) June 23, 2014 The Paxil birth defect lawyers at Wright & Schulte LLC note that GlaxoSmithKline has agreed to pay $105 million to resolve criminal and civil charges that it purportedly improperly marketed Paxil and other drugs. According to a report...

2014-06-21 12:20:21

DALLAS, June 21, 2014 /PRNewswire/ -- MarketOptimizer.org offers "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam" and "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines" market research reports in its store. The pharmaceutical market in Vietnam is set to increase at an impressive 15.4% CAGR to 2020 whereas the Philippines' pharmaceutical industry will grow at 9.4% CAGR to 2020. In Vietnam, the scarcity of...

2014-06-17 08:30:31

Takeda and Lundbeck Announce Results at American Society of Clinical Psychopharmacology Annual Meeting HOLLYWOOD, Fla., June 17, 2014 /PRNewswire/ -- Takeda Pharmaceuticals Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the companies will present results about sexual functioning from a head-to-head study of Brintellix(®) (vortioxetine) vs. escitalopram in patients with well treated major depressive disorder (MDD) experiencing treatment-emergent sexual...

2014-06-16 08:27:34

Takeda and Lundbeck to Present Late-breaker at International College of Neuropsychopharmacology World Congress VANCOUVER, British Columbia, June 16, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced results from CONNECT, a new study that evaluated the effect of Brintellix 10-20 mg/d on aspects of cognitive function, using an objective neuropsychological test (the Digit Symbol Substitution Test or DSST) associated with executive...

2014-06-11 16:27:28

ResolveHerpes is Designed to Boost the Body's Immune System and Allow it to Clear Out the Herpes Viruses HSV-1 and HSV-2 LOS ANGELES, June 11, 2014 /PRNewswire-iReach/ -- Resolve Herpes, a company that offers all-natural mineral formulations, has just announced the launch of a new and effective herpes treatment. Called ResolveHerpes, the product is designed to help boost the body's immune system, which in turn can help it naturally clear out the herpes viruses HSV-1 and HSV-2. Photo...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related